Twitter Logo Youtube Circle Icon LinkedIn Icon

The Legal 500 Hall of Fame Icon The Legal 500 Hall of Fame highlights individuals who have received constant praise by their clients for continued excellence. The Hall of Fame highlights, to clients, the law firm partners who are at the pinnacle of the profession. In the United Kingdon, the criteria for entry is to have been recognised by The Legal 500 as one of the elite leading lawyers for eight years. These partners are highlighted below and throughout the editorial.
Click here for more details

United Kingdom > East Anglia > TMT (technology, media and telecoms) > Biotechnology > Law firm and leading lawyer rankings



Who Represents Who

Find out which law firms are representing which Biotechnology clients in East Anglia using The Legal 500's new comprehensive database of law firm/client relationships. Instantly search over 925,000 relationships, including over 83,000 Fortune 500, 46,000 FTSE350 and 13,000 DAX 30 relationships globally. Access is free for in-house lawyers, and by subscription for law firms. For more information, contact


Taylor Wessing LLP is ‘among the very best; quick to respond and good value for money, the service is very good not only from the partners, but also from the associates’. Clients are quick to praise David Mardle for private equity matters and national head of life sciences Malcolm Bates, who has ‘excellent knowledge of the life sciences business and the needs of his clients’. The firm operates the Synapse online portal, a dedicated service focused on keeping life sciences sector clients updated with developments across the industry. Mardle advised drug and vaccine development company Kymab on a $100m Series C financing led by ORI Healthcare Fund. Bates advised Kymab on a collaboration and cross-finance agreement with China-based EpimAb BioTherapeutics Inc. to develop antibody technology. The Cambridge-based team also acted for publicly listed French biotech company TxCell on a licensing agreement with the European research institute at Ospedale San Raffaele to develop chimeric antigen receptor engineered regulatory T cell therapy products for the treatment of immune-mediated inflammatory diseases. IP and regulatory expert Tim Worden is also recommended. Gene and cell therapy company Oxford BioMedica and cancer genomics company Inivata are also clients.

Clients note the ‘excellent service at reasonable rates’ from the team at Mills & Reeve LLP, which provides the full range of commercial, regulatory and IP advice to the biotechnology sector. Life sciences expert and head of intellectual property Alasdair Poore leads the team. Corporate partner Stephen Hamilton advised Mercia Technologies on the AIM listing of its portfolio company Concepta Diagnostics, which develops products for the personalised mobile health market. Finance specialist Zickie Lim assisted IQ Capital with funding for its £5m investment in University of Cambridge spinout Fluid Analytics, which is active in the field of protein characterisation. Also recommended are corporate partner Anthony McGurk, litigator Graeme Menzies and Kevin Calder, who handles commercial contracts for biotechnology businesses. Isabel Napper retired. The firm’s other clients include BUPA, the University of Cambridge, Bayer Crop Science and AstraZeneca.

intellectual property boutique Marks & Clerk Solicitors has specialist knowledge of the biotechnology sector. Its diverse client base includes start-up life sciences companies, spinouts from the University of Cambridge and multinational enterprises. Managing associate and corporate team head Simon Portman advises local businesses as well as national and international companies with interests in East Anglia. He acted for IOmet Pharma, which focuses on the development of small molecules that disrupt transporters and enzymes in tumour cells, on its negotiations with licensees and investors. He also advised Psyomics on the licensing of IP for the use of diagnostics to prevent and treat neuropsychiatric disorders.

Penningtons Manches LLP is ‘particularly strong in biotech and technology, which is a real differentiator in the market’, says one client. The team is ‘punctual, responsive, committed, focused and commercial in its approach, always providing a depth of technical expertise’. ‘Professional, yet approachable’ corporate partner Ross McNaughtonprovides fantastic client service’. Senior associate Rachel Bradley is recommended for commercial IP and life sciences matters. She advised on an out-licence agreement of patented technology from a large biotech company and advised a pharmaceutical company on clinical collaboration agreements.

Interview with...

Law firm partners and practice heads explain how their firms are adapting to clients' changing needs

GC Diversity and Inclusion Report

In partnership with...

International comparative guides

Giving the in-house community greater insight to the law and regulations in different jurisdictions.

Select Practice Area

Press releases

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to

Legal Developments in East Anglia for Biotechnology

Legal Developments in the UK

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

Press Releases in the UK

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to